Revisi per 19 Agustus 2020 14.35 sunting Rachmat04 (bicara \| kontrib) Birokrat, Pengurus antarmuka, Pengurus 66.100 suntingan k Reverted to revision 17301627 by Rachmat04 (talk) Tag: Pembatalan ← Revisi sebelumnya		Revisi per 1 Maret 2021 19.31 sunting balikkan InternetArchiveBot (bicara \| kontrib) Bot 689.159 suntingan Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.8 Revisi selanjutnya →
Baris 49: \| molecular_weight = 345.42 g/mol \| smiles = Cc1c(OC)c(C)cnc1CS(=O)c2nc3ccc(OC)cc3n2 \| bioavailability= 35–76%<ref>[http://www1.astrazeneca-us.com/pi/Prilosec.pdf Prilosec Prescribing Information] {{Webarchive\|url=https://web.archive.org/web/20100216022020/http://www1.astrazeneca-us.com/pi/Prilosec.pdf \|date=2010-02-16 }}. AstraZeneca Pharmaceuticals.</ref><ref>{{cite journal\| last1 = Vaz-Da-Silva \| first1 = M\| last2 = Loureiro \| first2 = AI\| last3 = Nunes \| first3 = T\| last4 = Maia \| first4 = J\| last5 = Tavares \| first5 = S\| last6 = Falcão \| first6 = A\| last7 = Silveira \| first7 = P\| last8 = Almeida \| first8 = L\| last9 = Soares-Da-Silva \| first9 = P\| title = Bioavailability and bioequivalence of two enteric-coated formulations of omeprazole in fasting and fed conditions\| journal = Clinical Drug Investigation\| volume = 25\| issue = 6\| pages = 391–9\| year = 2005\| pmid = 17532679\| url = http://www.medscape.com/viewarticle/508018\| doi = 10.2165/00044011-200525060-00004}}</ref> \| protein_bound = 95% \| metabolism = [[Liver\|Hepatic]] ([[CYP2C19]], [[CYP3A4]])

Omeprazol: Perbedaan antara revisi